Skip to main content
NewslettersWatchlist

Senseonics Holdings(SENS-A)
NYSE Arca

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low0.4628
Day High0.4901
Open:0.4852
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.
Select a category then submit the form to load news
PR Newswire
Ascensia Diabetes Care and Senseonics Announce 'The CGM for Real Life' Campaign to Raise Awareness of How Long-Term Eversense E3 Empowers People with Diabetes
PR Newswire
ASCENSIA DIABETES CARE EXPANDS PAYMENT ASSISTANCE AND SIMPLE SAVINGS PROGRAM FOR EVERSENSE E3 CGM SYSTEM
Business Wire
Senseonics Holdings, Inc. Schedules First Quarter 2023 Earnings Release and Conference Call for May 9, 2023, at 4:30 p.m. Eastern Time
PR Newswire
ASCENSIA DIABETES CARE MARKS ONE-YEAR ANNIVERSARY OF US EVERSENSE E3 CGM LAUNCH WITH COMMERCIAL UPDATE AND INNOVATION OUTLOOK
Business Wire
Senseonics Announces the First Pediatric Study Participant Insertions in the ENHANCE Clinical Trial
Business Wire
Senseonics Announces Equity Grants To Employees Under Inducement Plan
Business Wire
Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2022 Financial Results
Business Wire
Senseonics Holdings, Inc. and PHC Holdings Corporation To Host Joint Eversense CGM Virtual Analyst and Investor Event on March 15, 2023
Business Wire
Senseonics Announces Equity Grants To Employees Under Inducement Plan
Business Wire
Energous Collaborates with Sensirion to Develop Wirelessly Powered CO2 Sensors
Business Wire
Senseonics to Present at the Stifel 2022 Healthcare Conference
Business Wire
Senseonics Holdings, Inc. Reports Third Quarter 2022 Financial Results
Business Wire
Senseonics and Ascensia Announce a Collaboration with the Nurse Practitioner Group Designed to Expand Patient Access by Providing In-Office and At-Home Insertion Options for Eversense® E3 Continuous Glucose Monitoring System (CGM)
Business Wire
Senseonics Holdings, Inc. Schedules Third Quarter 2022 Earnings Release and Conference Call for November 8, 2022, at 4:30 p.m. Eastern Time
Business Wire
Senseonics Announces Equity Grants To Employees Under Inducement Plan
Business Wire
Senseonics to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference
Business Wire
Senseonics Announces CFO Transition
Business Wire
Senseonics to Present at the Inaugural Gilmartin Group Emerging Growth Company Showcase
Business Wire
Senseonics Holdings, Inc. Reports Second Quarter 2022 Financial Results
Business Wire
Senseonics Announces a Positive Coverage Decision for Eversense® E3 CGM from Anthem
Business Wire
Senseonics Holdings, Inc. Schedules Second Quarter 2022 Earnings Release and Conference Call for August 9, 2022, at 4:30 p.m. Eastern Time
Business Wire
Senseonics Announces Equity Grants To Employees Under Inducement Plan
Business Wire
Senseonics Announces CE Mark Approval of the Eversense E3 Continuous Glucose Monitoring System
Business Wire
Senseonics to Participate in the Jefferies Healthcare Conference
Business Wire
Senseonics to Participate in the H.C. Wainwright Global Investment Conference
Business Wire
Senseonics Holdings, Inc. Reports First Quarter 2022 Financial Results
Business Wire
Senseonics Holdings, Inc. Schedules First Quarter 2022 Earnings Release and Conference Call for May 10, 2022, at 4:30 p.m. Eastern Time
Business Wire
Senseonics Announces the First Patient Implant of the Eversense E3 CGM System in the U.S.
Business Wire
Senseonics Announces Equity Grants to Employees Under Inducement Plan
Business Wire
Senseonics Holdings, Inc. Schedules Fourth Quarter and Full Year 2021 Earnings Release and Conference Call for March 1, 2022, at 4:30 p.m. Eastern Time
Business Wire
Senseonics Announces FDA Approval of the Eversense® E3 Continuous Glucose Monitoring System for Use for Up to 6 months; Provides 2022 Business Outlook
Business Wire
Senseonics Announces Equity Grants To Employees Under Inducement Plan

Profile

Senseonics Holdings, Inc. is a medical technology company which focused on the design, development and commercialization of glucose monitoring systems. Senseonics Holdings, Inc. is based in Germantown, United States.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2024.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2024 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.